BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34805154)

  • 1. Combinatorial Analysis of AT-Rich Interaction Domain 1A and CD47 in Gastric Cancer Patients Reveals Markers of Prognosis.
    Zhao Q; Cai Q; Yu S; Ji J; Zhu Z; Yan C; Zhang J
    Front Cell Dev Biol; 2021; 9():745120. PubMed ID: 34805154
    [No Abstract]   [Full Text] [Related]  

  • 2. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
    Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
    Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
    PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma.
    Yang H; Yan M; Li W; Xu L
    J Transl Med; 2022 Mar; 20(1):140. PubMed ID: 35317832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
    Kim YB; Ahn JM; Bae WJ; Sung CO; Lee D
    Int J Cancer; 2019 Aug; 145(4):916-926. PubMed ID: 30664822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.
    Wang X; Che K; Shi T; Liu Q; Xu X; Wu H; Yu L; Liu B; Wei J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1583-1595. PubMed ID: 35294647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration.
    Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
    Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
    J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
    Sun M; Gu Y; Fang H; Shao F; Lin C; Zhang H; Li H; He H; Li R; Wang J; Liu H; Xu J
    Cancer Sci; 2024 Mar; 115(3):905-915. PubMed ID: 38148578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
    Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
    Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of CD47 and signal-regulatory protein-α constituting the "don't eat me signal" is a prognostic factor in diffuse large B-cell lymphoma.
    Kazama R; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yoshida N; Kawamoto K; Yanagida E; Yamada K; Umeno T; Suzuki T; Kato K; Takizawa J; Seto M; Akashi K; Ohshima K
    Cancer Sci; 2020 Jul; 111(7):2608-2619. PubMed ID: 32342603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
    Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
    Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas.
    Dancsok AR; Gao D; Lee AF; Steigen SE; Blay JY; Thomas DM; Maki RG; Nielsen TO; Demicco EG
    Oncoimmunology; 2020; 9(1):1747340. PubMed ID: 32313727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
    Baldi S; Khamgan H; Qian Y; Wu H; Zhang Z; Zhang M; Gao Y; Safi M; Al-Radhi M; Zuo YF
    Front Oncol; 2021; 11():679334. PubMed ID: 34414106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of miR-340 controls pancreatic cancer cell
    Xi Q; Zhang J; Yang G; Zhang L; Chen Y; Wang C; Zhang Z; Guo X; Zhao J; Xue Z; Li Y; Zhang Q; Da Y; Liu L; Yao Z; Zhang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1.
    Zhang Q; Yan HB; Wang J; Cui SJ; Wang XQ; Jiang YH; Feng L; Yang PY; Liu F
    Oncotarget; 2016 Jul; 7(29):46127-46141. PubMed ID: 27323812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
    Han N; Kim MA; Lee HS; Kim WH
    Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
    Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):739-747. PubMed ID: 33392661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.